The Center for Cancer and Metabolism engages in cutting-edge research on metabolic dysregulation in cancer.
The Center for Cancer and Metabolism has raised $11.4M in total funding. The most recent round was Grant. The last funding was announced in May 2022.
The Center for Cancer and Metabolism's investors include National Institute of General Medical Science.
The Center for Cancer and Metabolism is headquartered in Lexington, United States.
The Center for Cancer and Metabolism engages in cutting-edge research on metabolic dysregulation in cancer.
The Center for Cancer and Metabolism is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"The Center for Cancer and Metabolism — Funding & Investors." VCBacked, May 25, 2022, https://www.vcbacked.co/company/the-center-for-cancer-and-metabolism. Accessed August 14, 2026.
VCBacked. (2022). The Center for Cancer and Metabolism — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/the-center-for-cancer-and-metabolism
{{cite web |title=The Center for Cancer and Metabolism — Funding & Investors |url=https://www.vcbacked.co/company/the-center-for-cancer-and-metabolism |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated